miR-206 inhibits cell migration through direct targeting of the actin-binding protein Coronin 1C in triple-negative breast cancer

Molecular Oncology

Volumn 8, Issue 8, 2014, Pages 1690-1702

  Wang, Jun ^a   Tsouko, Efrosini ^a   Jonsson, Philip ^a   Bergh, Jonas ^b   Hartman, Johan ^b   Aydogdu, Eylem ^a   Williams, Cecilia ^a  

^a University of Houston   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Breast cancer; Cell migration; CORO1C; MiR 206

Indexed keywords

ACTIN; ACTIN BINDING PROTEIN; COMPLEMENTARY DNA; CORONIN 1C; MESSENGER RNA; MICRORNA; MICRORNA 206; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ACTIN FILAMENT; ANIMAL CELL; ARTICLE; BIOINFORMATICS; BREAST CANCER CELL LINE; CANCER CELL CULTURE; CELL COUNTING; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DNA SYNTHESIS; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS INHIBITION; METASTASIS POTENTIAL; MIGRATION INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RNA EXTRACTION; SURVIVAL RATE; TRIPLE NEGATIVE BREAST CANCER; WESTERN BLOTTING; WOUND HEALING;

EID: 84911966142     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2014.07.006     Document Type: Article

References (41)

1. Adams B.D., Furneaux H., White B.A. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol. Endocrinol. 2007, 21:1132-1147.
2. Arjonen A., Kaukonen R., Ivaska J. Filopodia and adhesion in cancer cell motility. Cell Adh Migr 2011, 5:421-430.
3. Aydogdu E., Katchy A., Tsouko E., Lin C.Y., Haldosen L.A., Helguero L., Williams C. MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer. Carcinogenesis 2012, 33:1502-1511.
4. Ben-Porath I., Thomson M.W., Carey V.J., Ge R., Bell G.W., Regev A., Weinberg R.A. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 2008, 40:499-507.
5. Cai L., Marshall T.W., Uetrecht A.C., Schafer D.A., Bear J.E. Coronin 1B coordinates Arp2/3 complex and cofilin activities at the leading edge. Cell 2007, 128:915-929.
6. Chan K.T., Roadcap D.W., Holoweckyj N., Bear J.E. Coronin 1C harbours a second actin-binding site that confers co-operative binding to F-actin. Biochem. J. 2012, 444:89-96.
7. Chen J.F., Tao Y., Li J., Deng Z., Yan Z., Xiao X., Wang D.Z. microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J.Cell Biol. 2010, 190:867-879.
8. Curtis C., Shah S.P., Chin S.F., Turashvili G., Rueda O.M., Dunning M.J., Speed D., Lynch A.G., Samarajiwa S., Yuan Y., Graf S., Ha G., Haffari G., Bashashati A., Russell R., McKinney S., Langerod A., Green A., Provenzano E., Wishart G., Pinder S., Watson P., Markowetz F., Murphy L., Ellis I., Purushotham A., Borresen-Dale A.L., Brenton J.D., Tavare S., Caldas C., Aparicio S. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012, 486:346-352.
9. Dent R., Trudeau M., Pritchard K.I., Hanna W.M., Kahn H.K., Sawka C.A., Lickley L.A., Rawlinson E., Sun P., Narod S.A. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin. Cancer Res. 2007, 13:4429-4434.
10. Dey B.K., Gagan J., Dutta A. miR-206 and -486 induce myoblast differentiation by downregulating Pax7. Mol. Cell Biol. 2010, 31:203-214.
11. Foulkes W.D., Smith I.E., Reis-Filho J.S. Triple-negative breast cancer. N.Engl. J. Med. 2010, 363:1938-1948.
12. Gandhi M., Goode B.L. Coronin: the double-edged sword of actin dynamics. Subcell Biochem. 2008, 48:72-87.
13. Gluz O., Liedtke C., Gottschalk N., Pusztai L., Nitz U., Harbeck N. Triple-negative breast cancer-current status and future directions. Ann. Oncol. 2009, 20:1913-1927.
14. Goldman M., Craft B., Swatloski T., Ellrott K., Cline M., Diekhans M., Ma S., Wilks C., Stuart J., Haussler D., Zhu J. The UCSC Cancer Genomics Browser: update 2013. Nucleic Acids Res. 2013, 41:D949-D954.
15. Gupta G.P., Massague J. Cancer metastasis: building a framework. Cell 2006, 127:679-695.
16. Gyorffy B., Lanczky A., Eklund A.C., Denkert C., Budczies J., Li Q., Szallasi Z. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res. Treat. 2010, 123:725-731.
17. Helfman D.M., Berthier C., Grossman J., Leu M., Ehler E., Perriard E., Perriard J.C. Nonmuscle tropomyosin-4 requires coexpression with other low molecular weight isoforms for binding to thin filaments in cardiomyocytes. J.Cell Sci. 1999, 112:371-380.
18. Kondo N., Toyama T., Sugiura H., Fujii Y., Yamashita H. miR-206 expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res. 2008, 68:5004-5008.
19. Li Y., Hong F., Yu Z. Decreased expression of microRNA-206 in breast cancer and its association with disease characteristics and patient survival. J.Int. Med. Res. 2013, 41:596-602.
20. Maelan A.E., Rasmussen T.K., Larsson L.I. Localization of thymosin beta10 in breast cancer cells: relationship to actin cytoskeletal remodeling and cell motility. Histochem. Cell Biol. 2007, 127:109-113.
21. Mishra P.J., Merlino G. MicroRNA reexpression as differentiation therapy in cancer. J.Clin. Invest. 2009, 119:2119-2123.
22. Missiaglia E., Shepherd C.J., Patel S., Thway K., Pierron G., Pritchard-Jones K., Renard M., Sciot R., Rao P., Oberlin O., Delattre O., Shipley J. MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. Br. J. Cancer 2010, 102:1769-1777.
23. Qian X., Li G., Vass W.C., Papageorge A., Walker R.C., Asnaghi L., Steinbach P.J., Tosato G., Hunter K., Lowy D.R. The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis. Cancer Cell 2009, 16:246-258.
24. Ren G.P., Tian Q.M.D., An Y.M.D., Feng B.P., Lu Y.P., Liang J.P., Li K.P., Shang Y.P., Nie Y.P., Wang X.P., Fan D.P. Coronin 3 promotes gastric cancer metastasis via the up-regulation of MMP-9 and cathepsin K. Mol. Cancer 2012, 11:67-76.
25. Roadcap D.W., Clemen C.S., Bear J.E. The role of mammalian coronins in development and disease. Subcell Biochem. 2008, 48:124-135.
26. Rosentreter A., Hofmann A., Xavier C.P., Stumpf M., Noegel A.A., Clemen C.S. Coronin 3 involvement in F-actin-dependent processes at the cell cortex. Exp. Cell Res. 2007, 313:878-895.
27. Shenouda S.K., Alahari S.K. MicroRNA function in cancer: oncogene or a tumor suppressor?. Cancer Metastasis Rev. 2009, 28:369-378.
28. Song G., Zhang Y., Wang L. MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation. J.Biol. Chem. 2009, 284:31921-31927.
29. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Thorsen T., Quist H., Matese J.C., Brown P.O., Botstein D., Lonning P.E., Borresen-Dale A.L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U S A 2001, 98:10869-10874.
30. Taulli R., Bersani F., Foglizzo V., Linari A., Vigna E., Ladanyi M., Tuschl T., Ponzetto C. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J.Clin. Invest. 2009, 119:2366-2378.
31. Tavazoie S.F., Alarcon C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L., Massague J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451:147-152.
32. Thal D., Xavier C.P., Rosentreter A., Linder S., Friedrichs B., Waha A., Pietsch T., Stumpf M., Noegel A., Clemen C. Expression of coronin-3 (coronin-1C) in diffuse gliomas is related to malignancy. J.Pathol. 2008, 214:415-424.
33. Uetrecht A.C., Bear J.E. Coronins: the return of the crown. Trends Cell Biol. 2006, 16:421-426.
34. Wang X., Ling C., Bai Y., Zhao J. MicroRNA-206 is associated with invasion and metastasis of lung cancer. Anat. Rec. (Hoboken) 2010, 294:88-92.
35. Wang Y., Klijn J.G., Zhang Y., Sieuwerts A.M., Look M.P., Yang F., Talantov D., Timmermans M., Meijer-van Gelder M.E., Yu J., Jatkoe T., Berns E.M., Atkins D., Foekens J.A. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005, 365:671-679.
36. Williams C., Helguero L., Edvardsson K., Haldosen L.A., Gustafsson J.A. Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression. Breast Cancer Res. 2009, 11:26-42.
37. Wu L., Peng C.W., Hou J.X., Zhang Y.H., Chen C., Chen L.D., Li Y. Coronin-1C is a novel biomarker for hepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validation. J.Exp. Clin. Cancer Res. 2010, 29:17-25.
38. Yan D., Dong Xda E., Chen X., Wang L., Lu C., Wang J., Qu J., Tu L. MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. J.Biol. Chem. 2009, 284:29596-29604.
39. Yau C., Esserman L., Moore D.H., Waldman F., Sninsky J., Benz C.C. A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer. Breast Cancer Res. 2010, 12:85-99.
40. Zhang B., Pan X., Cobb G.P., Anderson T.A. microRNAs as oncogenes and tumor suppressors. Dev. Biol. 2007, 302:1-12.
41. Zhang T., Liu M., Wang C., Lin C., Sun Y., Jin D. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Res. 2011, 31:3859-3863.